Results 11 to 20 of about 45,444 (286)

Association Between SARS-CoV-2 Vaccination and Development of Antinuclear Antibodies Among Students [PDF]

open access: yesJournal of Primary Care & Community Health
Introduction: Antinuclear antibodies (ANA) are the hallmark of many connective tissue disorders (including lupus), which comprise roughly 5% to 10% of chronic debilitating diseases causing morbidity and mortality.
Karol Laskowski   +4 more
doaj   +3 more sources

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

open access: yesNeurobiology of Disease, 2013
There are overwhelming data supporting the inflammatory origin of some epilepsies (e.g., Rasmussen's encephalitis and limbic encephalitis). Inflammatory epilepsies with an autoimmune component are characterized by autoantibodies against membrane-bound ...
Philip H. Iffland, II   +8 more
doaj   +2 more sources

Antinuclear antibodies

open access: yesAutoimmunity, 2005
The presence of abnormal levels of autoantibodies to intracellular antigens is a hallmark of systemic connective tissue disease. The indirect immunofluorescence assay is the most commonly used routine test for the detection of antinuclear antibodies.
Yoshinao Muro
exaly   +3 more sources

Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children

open access: yesThe Turkish Journal of Pediatrics, 1999
The frequency of antinuclear antibodies (ANA) and rheumatoid factor (RF) was investigated in 118 apparently healthy children (56 male, 62 female). The mean age was 9.8 ± 2.3 years.
Özgür Kasapçopur   +5 more
doaj   +2 more sources

Fully automated chemiluminescence microarray immunoassay for detection of antinuclear antibodies in systemic autoimmune rheumatic diseases

open access: yesJournal of Laboratory Medicine
Detection of specific antinuclear antibodies is very important in term of diagnosis, prognosis and management of patients with systemic autoimmune rheumatic diseases.
Yuan Dandan   +8 more
doaj   +2 more sources

A study of clinical manifestations and their association with antinuclear antibodies in various autoimmune connective tissue disorders

open access: yesIndian Journal of Dermatology, 2023
Background: Autoimmune connective tissue diseases (AICTD) present with a myriad of clinical manifestations, including cutaneous. These disorders occur because of immune dysregulation that produces autoantibodies targeting connective tissue and internal ...
Rupa D Kondeti   +5 more
doaj   +2 more sources

Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited [PDF]

open access: yesDiagnostic Pathology, 2009
It has been more than 50 years since antinuclear antibodies were first discovered and found to be associated with connective tissue diseases. Since then different methods have been described and used for their detection or confirmation.
Minz Ranjana   +2 more
doaj   +2 more sources

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +2 more sources

Antinuclear antibodies in COVID 19 [PDF]

open access: yesClinical and Translational Science, 2021
We appreciated very much the interesting study by Chang et al. on the presence of antinuclear antibodies (ANAs) in patients with moderate/critical coronavirus disease 2019 (COVID 19).
Paolo Muratori   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy